All news
Closing the Gap between Hype and Hope: New Report Examines How Health Systems Can Prepare for the Future of Cancer Diagnosis
15 July 2024The Health Policy Partnership (HPP) has worked with an expert steering committee to publish a report outlining the policy actions needed to prepare...
Do You Want to Have a Say in which Treatments Will Be Available in EU Countries? Get involved in EU HTA
22 June 2024HTA Regulation will involve patients in joint technology assessments at the EU level for oncology treatments. This will utilise patients’ kno...
Will the New European Parliament be a Healthy One?
22 June 2024After the European elections, negotiations are currently taking place to shape the new, influential European Parliament. Although health is typical...
Uniting for Liver Health: DiCE Advances Dialogue at the 59th EASL Congress in Milan
22 June 2024Digestive Cancers Europe was an active participant in the 59th edition of the European Association for the Study of the Liver Congress in Milan fro...
Empowering Patients Together: DiCE and EUPATI Join Forces
21 June 2024We are happy to share that Digestive Cancers Europe (DiCE) and the European Patients’ Academy on Therapeutic Innovation (EUPATI) have teamed up t...
Launching the Gastric Cancer Project Promotion: A Step Forward in Patient Care
18 June 2024April 24, 2024 — The Recover with Us Association is thrilled to announce the launch of the Gastric Cancer Project Promotion, made possible by the...
Putting a Spotlight on Digestive Cancers in the Polish Parliament
27 May 2024On May 21, DiCE, together with our Polish member organisation EuropaColon Poland Foundation, had the pleasure of voicing the concerns of digestive ...
GUIDE.MRD Consortium Holds Productive 2nd Annual General Assembly in Hamburg
17 May 2024The GUIDE.MRD consortium’s 2nd annual general assembly in Hamburg discussed progress and challenges across all work packages, with over 30 pa...
EMA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer
17 May 2024Irinotecan hydrochloride trihydrate (Onivyde pegylated liposomal) was approved in March 2024 by the European Medicines Agency (EMA). Indications: N...
Advancing Right to be Forgotten
17 May 2024In a recent conference entitled ‘Cancer Survivorship: advancing the right to be forgotten – stocktaking of progress and challenges’, ...
